Granahan Investment Management ENANTA PHARMACEUTICALS IN ownership

ENANTA PHARMACEUTICALS IN's ticker is ENTA and the CUSIP is 29251M106. A total of 135 filers reported holding ENANTA PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.

Granahan Investment Management ownership history of ENANTA PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$3,090
-77.7%
43,414
-76.6%
0.08%
-73.0%
Q4 2021$13,865
+33.5%
185,411
+1.4%
0.28%
+44.7%
Q3 2021$10,386
+18.0%
182,816
-8.6%
0.20%
+20.1%
Q2 2021$8,801
-7.7%
199,970
+3.4%
0.16%
-18.8%
Q1 2021$9,539
-1.9%
193,416
-16.3%
0.20%
-7.3%
Q4 2020$9,728
+12.9%
231,071
+22.8%
0.22%
-25.3%
Q3 2020$8,614
-16.5%
188,164
-8.4%
0.29%
-21.7%
Q2 2020$10,313
+35.0%
205,400
+38.2%
0.37%
-9.5%
Q1 2020$7,642
-17.1%
148,600
-0.5%
0.41%
-2.8%
Q4 2019$9,223
+3.3%
149,293
+0.5%
0.42%
-13.6%
Q3 2019$8,928
-26.4%
148,604
+3.3%
0.49%
-18.2%
Q2 2019$12,134
-16.1%
143,799
-5.0%
0.60%
-22.7%
Q1 2019$14,454
+34.2%
151,322
-0.5%
0.78%
+1.7%
Q4 2018$10,767
+21.9%
152,007
+47.1%
0.76%
+59.3%
Q3 2018$8,830
-24.3%
103,320
+2.6%
0.48%
-31.9%
Q2 2018$11,668
+55.2%
100,670
+8.4%
0.70%
+29.5%
Q1 2018$7,517
+42.6%
92,907
+3.4%
0.54%
+30.8%
Q4 2017$5,270
+10.3%
89,811
-12.0%
0.42%
+4.3%
Q3 2017$4,776
-12.5%
102,041
-32.7%
0.40%
-20.9%
Q2 2017$5,458
-10.2%
151,695
-23.2%
0.50%
-17.5%
Q1 2017$6,080
-63.4%
197,408
-60.2%
0.61%
+6.8%
Q4 2016$16,617
+32.5%
496,025
+5.3%
0.57%
+38.9%
Q3 2016$12,537
+37.5%
471,135
+14.0%
0.41%
+23.8%
Q2 2016$9,116
-25.5%
413,415
-0.7%
0.33%
-25.4%
Q1 2016$12,230
+4.9%
416,425
+18.0%
0.44%
+11.0%
Q4 2015$11,657
-20.0%
353,025
-12.5%
0.40%
-11.1%
Q3 2015$14,580
+37.8%
403,430
+71.6%
0.45%
+50.8%
Q2 2015$10,578235,1300.30%